PREVALENCE OF ATTENTION-DEFICIENT/HYPERACTIVITY DISORDER CO-MORBIDITIES IN CHILDREN OF SOUTH JORDAN

Omar Ali Nafi

Abstract


The treatment success of attention-deficient/hyperactivity disorder (ADHD) is limited by misdiagnosis or underestimated co-existing conditions, including epilepsy, mental retardation, and autism spectrum disorder. The aim of this study was to document the prevalence of these three ADHD co-morbidities in a single patient population. A total of 107 children (3-12 years) evaluated for ADHD in our neurology clinic (clinical sample) were initially considered for this study. The existence of co-morbidities was determined using parent interview, family history, medical history, developmental history, and neurological evaluation. Results showed that 82 patients (M:F; 60:22) fulfilled the criteria for ADHD diagnosis. The patient population was composed of combined ADHD (51%), hyperactive/impulsive (28%). and inattentive (21%), Boys were about three times more likely to present with combined or hyperactive/impulsive ADHD compared to girls. Among all ADHD children, 70% presented co-morbidity: epilepsy ((29.3%), mental retardation (28%) or autistic spectrum disorder (12.2%). Such common occurrence suggests that the current protocols used to diagnose ADHD should be refined to identify these co-morbidities for the development of a new approach to ADHD. Our findings add relevant clinical information on ADHD from a world region where few clinical studies on this disorder have thus far been conducted.

Full Text:

PDF


DOI: http://dx.doi.org/10.19044/esj.2013.v9n20p%25p


European Scientific Journal (ESJ)

 

ISSN: 1857 - 7881 (Print)
ISSN: 1857 - 7431 (Online)

 

Contact: contact@eujournal.org

To make sure that you can receive messages from us, please add the 'eujournal.org' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.




Publisher: European Scientific Institute, ESI.
ESI cooperates with Universities and Academic Centres on 5 continents.